Tools
Sorted by:
Try your query at:
 |
 |
 |
 |
 |
 |
Results 1 - 10
of
6,103
advanced unresectable Hepatocellular Carcinoma
, 2012
"... Can we achieve complete remission in locally ..."
Radiofrequency Ablation in Unresectable Hepatocellular Carcinoma
"... ABSTRACT Purpose: Most patients with hepatocellular carcinoma (HCC) are not candidates for resection because of tumor size, location, multifocality, or liver dysfunction associated with liver cirrhosis and hepatitis. Radiofrequency ablation (RFA) offers an alternative treatment in some unresectable ..."
Abstract
- Add to MetaCart
ABSTRACT Purpose: Most patients with hepatocellular carcinoma (HCC) are not candidates for resection because of tumor size, location, multifocality, or liver dysfunction associated with liver cirrhosis and hepatitis. Radiofrequency ablation (RFA) offers an alternative treatment in some
unresectable hepatocellular carcinoma after a
"... www.impactjournals.com/oncotarget / Oncotarget, Vol. 6, No. 27 Sorafenib continuation or discontinuation in patients with ..."
Abstract
- Add to MetaCart
www.impactjournals.com/oncotarget / Oncotarget, Vol. 6, No. 27 Sorafenib continuation or discontinuation in patients with
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
"... located on the World Wide Web at: The online version of this article, along with updated information and services, is by guest on M arch 5, 2014 ..."
Abstract
- Add to MetaCart
located on the World Wide Web at: The online version of this article, along with updated information and services, is by guest on M arch 5, 2014
Percutaneous Radiofrequency Ablation in Treatment of Unresectable Hepatocellular Carcinoma
"... Objective: The purpose of this study was to compare laparoscopic ultrasound–guided radiofrequency ablation (LUSRFA) versus percutaneous radiofrequency ablation (PRFA) in treatment of localized hepatocellular carcinoma (HCC). Methods: From January 2005 through April 2008, for 60 consecutive patients, ..."
Abstract
- Add to MetaCart
Objective: The purpose of this study was to compare laparoscopic ultrasound–guided radiofrequency ablation (LUSRFA) versus percutaneous radiofrequency ablation (PRFA) in treatment of localized hepatocellular carcinoma (HCC). Methods: From January 2005 through April 2008, for 60 consecutive patients
• LIVER CANCER • Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma
"... AIM: To assess whether the effectiveness of a combination of transarterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) in the treatment of unresectable hepatocellular carcinoma (HCC) is superior to TACE alone a randomized controlled trial was performed. METHODS: The effect of c ..."
Abstract
- Add to MetaCart
AIM: To assess whether the effectiveness of a combination of transarterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) in the treatment of unresectable hepatocellular carcinoma (HCC) is superior to TACE alone a randomized controlled trial was performed. METHODS: The effect
Efficacy of surgical microwave therapy in patients with unresectable hepatocellular carcinoma,”
- Annals of Surgical Oncology,
, 2011
"... ABSTRACT Background. We aimed to evaluate the efficacy and longterm outcome in surgical microwave therapy (MW) for patients with unresectable hepatocellular carcinoma (HCC). Methods. An institutional review board approved and single-institutional study of surgical MW of unresectable HCC was conduct ..."
Abstract
-
Cited by 1 (0 self)
- Add to MetaCart
ABSTRACT Background. We aimed to evaluate the efficacy and longterm outcome in surgical microwave therapy (MW) for patients with unresectable hepatocellular carcinoma (HCC). Methods. An institutional review board approved and single-institutional study of surgical MW of unresectable HCC
Biologics: Targets & Therapy 2008:2(4) 779–788 779
"... Sorafenib for the treatment of unresectable hepatocellular carcinoma ..."
Phase 2 Study of Erlotinib in Patients With Unresectable Hepatocellular Carcinoma
"... BACKGROUND. Growth factor overexpression, including epidermal growth factor receptor (EGFR) expression, is common in hepatocellular cancers. Erlotinib is a receptor tyrosine kinase inhibitor with specificity for EGFR. The primary objec-tive of this study was to determine the proportion of hepatocell ..."
Abstract
-
Cited by 1 (0 self)
- Add to MetaCart
of hepatocellular carcinoma (HCC) patients treated with erlotinib who were alive and progression-free (PFS) at 16 weeks of continuous treatment. METHODS. Patients with unresectable HCC, no prior systemic therapy, perform-ance status (PS) of 0, 1, or 2, and Childs-Pugh (CP) cirrhosis A or B received oral erlotinib
SPECT-Based Radiation Therapy and Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma Sized 14 cm or Greater
"... We have no sources of financial support and there are no financial disclosures from any authors Conflicts of Interest: Actual or potential conflicts of interest do not exist Purpose: To evaluate the feasibility of single photon emission computed tomography-based three-dimensional conformal radiother ..."
Abstract
- Add to MetaCart
radiotherapy (SPECT-B3DCRT) combined with transcatheter arterial chemoembolization (TACE) for large unresectable hepatocellular carcinoma. Methods: Twelve patients with unresectable hepatocellular carcinoma (HCC) sized 14 cm or greater underwent SPECT using Tc-99m-galactosyl human serum albumin before 3DCRT
Results 1 - 10
of
6,103
